Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01295489 · ClinicalTrials.gov registry record

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

A clinical trial, sponsored by Gynecologic Oncology Group.

Completed
Registry status
39
Enrollment target

NCT01295489: Completed study, sponsored by Gynecologic Oncology Group.

NCT01295489 is a clinical trial that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01295489 has completed, sponsored by Gynecologic Oncology Group.

COMPLETED
Registry status
39 participants
Enrollment target

Study Summary

This research trial studies biomarkers in patients with previously untreated invasive ovarian epithelial, fallopian tube, or primary peritoneal cancer. Studying samples of tumor tissue, peritoneal cavity fluid, and blood from patients receiving chemotherapy directly into the abdominal cavity (intraperitoneal) may help doctors learn more about the effects of intraperitoneal chemotherapy on cells. It may also help doctors identify and learn more about biomarkers related to cancer.

Interventions

  • OTHER Laboratory Biomarker Analysis

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2011-03
Gynecologic Oncology Group

154 total trials

What the finished NCT01295489 record still lists

NCT01295489 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Laboratory Biomarker Analysis is the first listed.

NCT01295489 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01295489 about?

NCT01295489 is a clinical study titled "Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer". This research trial studies biomarkers in patients with previously untreated invasive ovarian epithelial, fallopian tube, or primary peritoneal cancer. Studying samples of tumor tissue, peritoneal cavity fluid, and blood from patients receiving chemotherapy directly into the abdominal cavity (intrap...

What is the current status of trial NCT01295489?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2011-03.

What interventions are being tested in trial NCT01295489?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER).

Who is sponsoring clinical trial NCT01295489?

This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01295489, the US trial registry maintained by the National Library of Medicine. NCT01295489 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.